The EHA Research Roadmap: Transfusion Medicine

Simon J. Stanworth; Anneke Brand; Srini V. Kaveri; Hans Vrielink; Andreas Greinacher; Dragoslav Domanović; Marieke von Lindern; Shubha Allard; Jagadeesh Bayry; Milos Bohonek; Andreas Buser; Frans H.J. Claas; Folke Knutson; Miguel Lozano; Martin L. Olsson; France Pirenne; Paolo Rebulla; Cynthia So-Osman; Jean Daniel Tissot; Ashley M. Toye; Ines Ushiro-Lumb; Emile van den Akker; Sacha Zeerleder

doi:10.1097/HS9.0000000000000670

The EHA Research Roadmap: Transfusion Medicine

Simon J. Stanworth^*, Anneke Brand, Srini V. Kaveri, Hans Vrielink, Andreas Greinacher, Dragoslav Domanović, Marieke von Lindern, Shubha Allard, Jagadeesh Bayry, Milos Bohonek, Andreas Buser, Frans H.J. Claas, Folke Knutson, Miguel Lozano, Martin L. Olsson, France Pirenne, Paolo Rebulla, Cynthia So-Osman, Jean Daniel Tissot, Ashley M. ToyeInes Ushiro-Lumb, Emile van den Akker, Sacha Zeerleder

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

2 Citations (Scopus)

Abstract

In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research¹ aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including eleven sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.

Original language	English
Pages (from-to)	E670
Journal	HemaSphere
Volume	6
Issue number	2
DOIs	https://doi.org/10.1097/HS9.0000000000000670
Publication status	Published - 25 Feb 2022
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. HemaSphere (2022) 6:2(e670).

Access to Document

10.1097/HS9.0000000000000670

Cite this

Stanworth, S. J., Brand, A., Kaveri, S. V., Vrielink, H., Greinacher, A., Domanović, D., von Lindern, M., Allard, S., Bayry, J., Bohonek, M., Buser, A., Claas, F. H. J., Knutson, F., Lozano, M., Olsson, M. L., Pirenne, F., Rebulla, P., So-Osman, C., Tissot, J. D., ... Zeerleder, S. (2022). The EHA Research Roadmap: Transfusion Medicine. HemaSphere, 6(2), E670. https://doi.org/10.1097/HS9.0000000000000670

@article{f3b6223b0b8c490f87f673c2e3ca2592,

title = "The EHA Research Roadmap: Transfusion Medicine",

abstract = "In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including eleven sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.",

author = "Stanworth, {Simon J.} and Anneke Brand and Kaveri, {Srini V.} and Hans Vrielink and Andreas Greinacher and Dragoslav Domanovi{\'c} and {von Lindern}, Marieke and Shubha Allard and Jagadeesh Bayry and Milos Bohonek and Andreas Buser and Claas, {Frans H.J.} and Folke Knutson and Miguel Lozano and Olsson, {Martin L.} and France Pirenne and Paolo Rebulla and Cynthia So-Osman and Tissot, {Jean Daniel} and Toye, {Ashley M.} and Ines Ushiro-Lumb and {van den Akker}, Emile and Sacha Zeerleder",

note = "Publisher Copyright: {\textcopyright} 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. HemaSphere (2022) 6:2(e670).",

year = "2022",

month = feb,

day = "25",

doi = "10.1097/HS9.0000000000000670",

language = "English",

volume = "6",

pages = "E670",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Lippincott, Williams & Wilkins",

number = "2",

}

Stanworth, SJ, Brand, A, Kaveri, SV, Vrielink, H, Greinacher, A, Domanović, D, von Lindern, M, Allard, S, Bayry, J, Bohonek, M, Buser, A, Claas, FHJ, Knutson, F, Lozano, M, Olsson, ML, Pirenne, F, Rebulla, P, So-Osman, C, Tissot, JD, Toye, AM, Ushiro-Lumb, I, van den Akker, E & Zeerleder, S 2022, 'The EHA Research Roadmap: Transfusion Medicine', HemaSphere, vol. 6, no. 2, pp. E670. https://doi.org/10.1097/HS9.0000000000000670

TY - JOUR

T1 - The EHA Research Roadmap

T2 - Transfusion Medicine

AU - Stanworth, Simon J.

AU - Brand, Anneke

AU - Kaveri, Srini V.

AU - Vrielink, Hans

AU - Greinacher, Andreas

AU - Domanović, Dragoslav

AU - von Lindern, Marieke

AU - Allard, Shubha

AU - Bayry, Jagadeesh

AU - Bohonek, Milos

AU - Buser, Andreas

AU - Claas, Frans H.J.

AU - Knutson, Folke

AU - Lozano, Miguel

AU - Olsson, Martin L.

AU - Pirenne, France

AU - Rebulla, Paolo

AU - So-Osman, Cynthia

AU - Tissot, Jean Daniel

AU - Toye, Ashley M.

AU - Ushiro-Lumb, Ines

AU - van den Akker, Emile

AU - Zeerleder, Sacha

N1 - Publisher Copyright: © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. HemaSphere (2022) 6:2(e670).

PY - 2022/2/25

Y1 - 2022/2/25

N2 - In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including eleven sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.

AB - In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1-2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including eleven sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cell-based Immune Therapies; and Gene Therapy.

UR - http://www.scopus.com/inward/record.url?scp=85124178219&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000670

DO - 10.1097/HS9.0000000000000670

M3 - Review article

AN - SCOPUS:85124178219

SN - 2572-9241

VL - 6

SP - E670

JO - HemaSphere

JF - HemaSphere

IS - 2

ER -

The EHA Research Roadmap: Transfusion Medicine

Abstract

Bibliographical note

Access to Document

Other files and links

Fingerprint

Cite this